Dual drug delivery system for targeting H. pylori in the stomach: Preparation and in vitro characterization of amoxicillin-loaded Carbopol® nanospheres

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 4787-4796

  Harsha, Sree ^a  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Amoxicillin; Helicobacter pylori; Nano spraydryer; Nanospheres; Optimization

Indexed keywords

AMOXICILLIN; CARBOMER; NANOPARTICLE;

ARTICLE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG SYNTHESIS; DRUG TARGETING; HELICOBACTER PYLORI; IN VITRO STUDY; NONHUMAN; PARTICLE SIZE; PROCESS OPTIMIZATION; STOMACH; SURFACE PROPERTY;

AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG COMBINATIONS; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; NANOCAPSULES; NANOSPHERES; PARTICLE SIZE; POLYVINYLS; SUSPENSIONS;

HELICOBACTER PYLORI;

EID: 84870329076     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S34312     Document Type: Article

References (35)

1. Hejazi R, Amiji M. Stomach-specific anti-H. pylori therapy. I: preparation and characterization of tetracycline-loaded chitosan microspheres. Int J Pharm. 2002;235(1-2):87-94.
2. Krueger S, Roessner A, Kuester D. Murine models of H. pylori-induced gastritis and gastric adenocarcinoma. Pathol Res Pract. 2011;207(10):599-607.
3. Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med. 1991;324(15):1043-1048.
4. Meurer LN, Bower DJ. Management of Helicobacter pylori infection. Am Fam Physician. 2002;65(7):1327-1336.
5. Romano M, Cuomo A. Eradication of Helicobacter pylori: a clinical update. Med Gen Med. 2004;17(6):19.
6. Lin CK, Hsu PI, Lai KH, etal. One-week quadruple therapy is an effective salvage regimen for Helicobacter pylori infection in patients after failure of standard triple therapy. J Clin Gastroenterol. 2002;34(5):547-551.
7. Liu Z, Lu W, Qian L, Zhang X, Zeng P, Pan J. In vitro and in vivo studies on mucoadhesive microspheres of amoxicillin. J Control Release. 2005;102(1):135-144.
8. Axon AT. The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol Suppl. 2004;201:16-23.
9. Fontana G, Licciardi M, Mansueto S, Schillaci D, Giammona G. Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials. 2001;22(21):2857-2865.
10. Patel JK, Chavda JR. Formulation and evaluation of stomach-specific amoxicillin-loaded Carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy. J Microencapsul. 2009;26(4):365-376.
11. Naoki N, Yohko A, Masafumi N, Mayumi T, Megumi K, Yasuyuki O. Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori. Antimicrob Agents Chemother. 1998;42(10):2492-2494.
12. Narkar M, Sher P, Pawar A. Stomach-specific controlled release gellan beads of acid-soluble drug prepared by ionotropic gelation method. AAPS Pharm Sci Tech. 2010;11(1):267-277.
13. Jain P, Jain S, Prasad KN, Jain SK, Vyas SP. Polyelectrolyte coated multilayered liposomes (nanocapsules) for the treatment of Helicobacter pylori infection. Mol Pharm. 2009;6(2):593-603.
14. Moogooee M, Ramezanzadeh H, Jasoori S, Omidi Y, Davaran S. Synthesis and in vitro studies of cross-linked hydrogel nanoparticles containing amoxicillin. J Pharm Sci. 2011;100(3):1057-1066.
15. Awasthi R, Kulkarni GT, Pawar VK, Garg G. Optimization studies on gastroretentive floating system using response surface methodology. AAPS Pharm Sci Tech: 2012;13(1):85-93.
16. Sambathkumar R, Venkateswaramurthy N, Vijayabaskaran M, Perumal P. Formulation of clarithromycin loaded mucoadhesive microspheres by emulsification-internal gelation technique for anti-Helicobacter pylori therapy. Int J Pharm Pharm Sci. 2011;3:173-177.
17. Rao JP, Geckeler KE. Polymer nanoparticles: preparation techniques and size-control parameters. Prog Polym Sci. 2011;36(70):887-913.
18. Lee SH, Heng D, Kiong WNG, Chan HK, Tan RBH. Nano spray drying: A novel method for preparing protein nanoparticles for protein therapy. Int J Pharm. 2011;403(1-2):192-200.
19. Sham JOH, Zhang Y, Finlay WH, Roa WH. Löbenberg R. Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung. Int J Pharm. 2004;269(2):457-467.
20. Pilcer G, Vanderbist F, Amighi K. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery. Int J Pharm. 2009;365(1-2):162-169.
21. Li X, Anton N, Arpagaus C, Belleteix F, Vandamme TF. Nanoparticles by spray drying using innovative new technology: The Buchi Nano Spray Dryer B-90. J Control Release. 2010;147(2):304-310.
22. Dhanaraju MD, RajKannan R, Selvaraj D, Jayakumar R, Vamsadhara C. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (dl-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study. Contraception. 2006;74(2):148-156.
23. Harsha S, Shobha R. Ofloxacin targeting to lungs by way of microspheres. Int J Pharm. 2009;380(1-2):127-132.
24. Nowacek AS, Balkundi S, McMillan J, etal. Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages. J Control Release. 2011;150(2):204-211.
25. Lu B, Zhang JQ, Yang H. Lung-targeting microspheres of carboplatin. Int J Pharm. 2003;265(1-2):1-11.
26. Harsha NS, Rani SH. Drug targeting to lungs by way of microspheres. Arch Pharm Res. 2006;29(7):598-604.
27. Singh SK, Chidrawar VR, Ushir YV, Vadalia KR, Sheth NR, Singh S. Pharmaceutical characterization of amoxicillin trihydrate as mucoadhesive microspheres in management of H. pylori. Pharm Tech. 2010;6(2):348-358.
28. Gomez-Estaca J, Balaguer MP, Gavara R, Hernandez-Munoz P. Formation of zein nanoparticles by electrohydrodynamic atomization: Effect of the main processing variables and suitability for encapsulating the food coloring and active ingredient curcumin. Food Hydrocolloids. 2011;28:82-91.
29. Devrim B, Bozkir A, Canefe K. Formulation and evaluation of reconstitutable suspensions containing ibuprofen-loaded Eudragit microspheres. Acta Pol Pharm. 2011;84(4):593-599.
30. Raula J, Eerikinen H, Kauppinen EI. Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles. Int J Pharm. 2004;284(1-2):13-21.
31. Tonon RV, Grosso CRF, Hubinger MD. Influence of emulsion composition and inlet air temperature on the microencapsulation of flaxseed oil by spray drying. Food Res Int. 2011;44(1):282-289.
32. Burki K, Jeon I, Arpagaus C, Betz G. New insights into respirable protein powder preparation using a nano spray dryer. Int J Pharm. 2011;408(1-2):248-256.
33. Wang LY, Gu YH, Su ZG, Ma GH. Preparation and improvement of release behavior of chitosan microspheres containing insulin. Int J Pharm. 2006;311(1-2):187-195.
34. Joscelyne SM, Trägårdh G. Membrane emulsification a literature review. J Memb Sci. 2000;169(1):107-117.
35. Mizoe T, Beppu S, Ozeki T, Okada H. One-step preparation of drug-containing microparticles to enhance the dissolution and absorption of poorly water-soluble drugs using a 4-fluid nozzle spray drier. J Control Release. 2007;120(3):205-210.